NCT02088216View on ClinicalTrials.gov

Effect of Long-term, High-dose N-acetylcysteine on Exacerbations of Bronchiectaisis

NACompletedINTERVENTIONAL
Enrollment

161

Participants

Timeline

Start Date

April 1, 2014

Primary Completion Date

December 1, 2017

Study Completion Date

March 30, 2018

Conditions
Non-Cystic Fibrosis Bronchiectasis
Interventions
DRUG

N-acetylcysteine

600mg po twice a day for 12 months

OTHER

On-demand treatment

receive as-needed therapy

Trial Locations (1)

250012

Qilu Hospital of Shandong University, Jinan

All Listed Sponsors
lead

Qilu Hospital of Shandong University

OTHER

NCT02088216 - Effect of Long-term, High-dose N-acetylcysteine on Exacerbations of Bronchiectaisis | Biotech Hunter | Biotech Hunter